| RS143456081 |
CPOX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143456239 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS143456575 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS1434566381 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, CHARGE syndrome |
| RS143456757 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS143456784 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS143456909 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS1434569440 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS143456960 |
GBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS143457316 |
SYNPO
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143457531 |
SUOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS1434575390 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1434577007 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1434577015 |
BBS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS143457794 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Inborn genetic diseases |
| RS143457874 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica inversa, autosomal recessive |
| RS1434578765 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1434578927 |
NPHS2
|
Health Risk |
Pathogenic |
— |
| RS143458628 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of esophagus, Ovarian serous cystadenocarcinoma |
| RS143458723 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS143458938 |
FDXR
|
Health Risk |
Conflicting classifications of pathogenicity |
Auditory neuropathy-optic atrophy syndrome, Inborn genetic diseases |
| RS143459232 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS143459302 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS1434599441 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1434601711 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS143460342 |
D2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
D-2-hydroxyglutaric aciduria 1, D2HGDH-related disorder |
| RS143461644 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS143461869 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS143462011 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Congenital contractural arachnodactyly |
| RS143462810 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, Centromeric instability of chromosomes 1 |
| RS1434631255 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1434632102 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome 1, Joubert syndrome 1 |
| RS1434632385 |
DRC2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 27, Primary ciliary dyskinesia 27 |
| RS143463683 |
WNT10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Schöpf-Schulz-Passarge syndrome, Odonto-onycho-dermal dysplasia |
| RS143464326 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Holoprosencephaly 7 |
| RS1434645720 |
MMUT
|
Health Risk |
Pathogenic |
— |
| RS143464806 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1434654558 |
IL12RB1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1434666715 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS143468222 |
SNCAIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson Disease, Dominant/Recessive |
| RS143468500 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial hypobetalipoproteinemia 1 |
| RS143468713 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS143470288 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 12, Stargardt disease 4 |
| RS143471343 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS143471358 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Inborn genetic diseases |
| RS143471549 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RTTN-related disorder |
| RS1434725624 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1434726192 |
CHD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Seizure |
| RS143472856 |
PTS
|
Health Risk |
Conflicting classifications of pathogenicity |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, PTS-related disorder |
| RS143473036 |
ABCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA2-related disorder, ABCA2-related disorder |
| RS143473050 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS143473183 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS143473232 |
HARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Charcot-Marie-Tooth disease type 2W, Autosomal dominant Charcot-Marie-Tooth disease type 2W |
| RS143473912 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Lamellar ichthyosis |
| RS143474365 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1434753563 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS143475751 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1434760802 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1434761678 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS143477104 |
RPS19
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 1 |
| RS143477126 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS143477190 |
PRKN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS143477661 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
carboxymethyl-dextran-A2-gadolinium-DOTA, 11p partial monosomy syndrome |
| RS143479340 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Inborn genetic diseases |
| RS1434804006 |
TBC1D32
|
Health Risk |
Likely pathogenic |
TBC1D32-related disorder, TBC1D32-related disorder |
| RS143480636 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143481004 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Inborn genetic diseases |
| RS1434810965 |
FGF3
|
Health Risk |
Pathogenic/Likely pathogenic |
FGF3-related disorder, Deafness with labyrinthine aplasia |
| RS1434813233 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, APC-related disorder |
| RS143481438 |
GNAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital stationary night blindness autosomal dominant 3, Congenital stationary night blindness 1G |
| RS143481916 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 4, Fibromatosis |
| RS1434821822 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1434829861 |
MMP21
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1434833641 |
HSD17B3
|
Health Risk |
Likely pathogenic |
— |
| RS143484278 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1434843098 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS143484733 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS143484849 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB11-related disorder, ABCB11-related disorder |
| RS143485040 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143485388 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS143485622 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome |
| RS143486492 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS1434865362 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS1434866164 |
F9
|
Health Risk |
Pathogenic |
Thrombophilia, X-linked |
| RS143486835 |
GPD1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome |
| RS1434874435 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Berardinelli-Seip congenital lipodystrophy |
| RS143487597 |
ITIH6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1434876636 |
ERCC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group B, Xeroderma pigmentosum |
| RS143488099 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS1434894149 |
CTSC
|
Health Risk |
Likely pathogenic |
Haim-Munk syndrome, Papillon-Lefèvre syndrome |
| RS1434898623 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1434902604 |
CACNA1S
|
Health Risk |
Pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS143490673 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS143491016 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Familial cancer of breast |
| RS143491269 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143491365 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1434914864 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS1434920074 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1434924240 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia |
| RS1434924385 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |